Downregulation of MicroRNA-146a in Diabetes, Obesity and Hypertension May Contribute to Severe COVID-19

Overview

Journal Med Hypotheses

Specialty General Medicine

Date 2020 Dec 18

PMID 33338955

Citations 39

Authors

Jelena Roganovic

Affiliations

Soon will be listed here.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is able to produce an excessive host immune reaction and may leads to severe disease- a life-threatening condition occurring more often in patients suffering from comorbidities such as hypertension, diabetes and obesity. Infection by human corona viruses highly depends on host microRNA (miR) involved in regulation of host innate immune response and inflammation-modulatory miR-146a is among the first miRs induced by immune reaction to a virus. Moreover, recent analysis showed that miR-146 is predicted to target at the SARS-CoV-2 genome. As the dominant regulator of Toll-like receptors (TLRs) downstream signaling, miR-146a may limit excessive inflammatory response to virus. Downregulation of circulating miR-146a was found in diabetes, obesity and hypertension and it is reflected by enhanced inflammation and fibrosis, systemic effects accompanying severe COVID-19. Thus it could be hypothesized that miR-146a deficiency may contribute to severe COVID-19 state observed in diabetes, obesity and hypertension but further investigations are needed.

Citing Articles

Comprehensive analysis of glycoprotein profiles and their association with cardiovascular disease-related microRNAs in rheumatoid arthritis, metabolic disorders, and controls.

LLop D, Paredes S, Rosales R, Amigo N, Masana L, Ribalta J Sci Rep. 2024; 14(1):26471.

PMID: 39488576 PMC: 11531556. DOI: 10.1038/s41598-024-77772-1.

Decoding the intricacies: a comprehensive analysis of microRNAs in the pathogenesis, diagnosis, prognosis and therapeutic strategies for COVID-19.

Smail S, Hirmiz S, Ahmed A, Albarzinji N, Awla H, Amin K Front Med (Lausanne). 2024; 11:1430974.

PMID: 39434774 PMC: 11492531. DOI: 10.3389/fmed.2024.1430974.

The relationship between microRNAs and COVID-19 complications.

Kebriaei A, Besharati R, Namdar Ahmad Abad H, Havakhah S, Khosrojerdi M, Azimian A Noncoding RNA Res. 2024; 10:16-24.

PMID: 39296641 PMC: 11406673. DOI: 10.1016/j.ncrna.2024.08.007.

Dual Role of microRNA-146a in Experimental Inflammation in Human Pulmonary Epithelial and Immune Cells and Expression in Inflammatory Lung Diseases.

Gronau L, Duecker R, Jerkic S, Eickmeier O, Trischler J, Chiocchetti A Int J Mol Sci. 2024; 25(14).

PMID: 39062931 PMC: 11276706. DOI: 10.3390/ijms25147686.

Gene Regulatory Network Analysis of Post-Mortem Lungs Unveils Novel Insights into COVID-19 Pathogenesis.

Bloomquist R, Mondal A, Vashisht A, Sahajpal N, Jones K, Vashisht V Viruses. 2024; 16(6).

PMID: 38932146 PMC: 11209433. DOI: 10.3390/v16060853.

References

Zhao J, Rao D, Boldin M, Taganov K, OConnell R, Baltimore D . NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A. 2011; 108(22):9184-9. PMC: 3107319. DOI: 10.1073/pnas.1105398108. View

Hijmans J, Diehl K, Bammert T, Kavlich P, Lincenberg G, Greiner J . Association between hypertension and circulating vascular-related microRNAs. J Hum Hypertens. 2018; 32(6):440-447. PMC: 6026553. DOI: 10.1038/s41371-018-0061-2. View

Sinha P, Matthay M, Calfee C . Is a "Cytokine Storm" Relevant to COVID-19?. JAMA Intern Med. 2020; 180(9):1152-1154. DOI: 10.1001/jamainternmed.2020.3313. View

Mitchell S, Vargas J, Hoffmann A . Signaling via the NFκB system. Wiley Interdiscip Rev Syst Biol Med. 2016; 8(3):227-41. PMC: 8363188. DOI: 10.1002/wsbm.1331. View

Makarova J, Shkurnikov M, Wicklein D, Lange T, Samatov T, Turchinovich A . Intracellular and extracellular microRNA: An update on localization and biological role. Prog Histochem Cytochem. 2016; 51(3-4):33-49. DOI: 10.1016/j.proghi.2016.06.001. View

Zhang J, Wang X, Jia X, Li J, Hu K, Chen G . Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; 26(6):767-772. PMC: 7159868. DOI: 10.1016/j.cmi.2020.04.012. View

Masselli E, Vaccarezza M, Carubbi C, Pozzi G, Presta V, Mirandola P . NK cells: A double edge sword against SARS-CoV-2. Adv Biol Regul. 2020; 77:100737. PMC: 7292949. DOI: 10.1016/j.jbior.2020.100737. View

Lu L, Boldin M, Chaudhry A, Lin L, Taganov K, Hanada T . Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010; 142(6):914-29. PMC: 3049116. DOI: 10.1016/j.cell.2010.08.012. View

Zhang T, Ma Y, Gao L, Mao C, Zeng H, Wang X . MicroRNA-146a protects against myocardial ischaemia reperfusion injury by targeting Med1. Cell Mol Biol Lett. 2019; 24:62. PMC: 6882197. DOI: 10.1186/s11658-019-0186-5. View

10.

Nahand J, Karimzadeh M, Nezamnia M, Fatemipour M, Khatami A, Jamshidi S . The role of miR-146a in viral infection. IUBMB Life. 2020; 72(3):343-360. DOI: 10.1002/iub.2222. View

11.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

12.

Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y . MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009; 60(4):1065-75. DOI: 10.1002/art.24436. View

13.

Kotb H, Ibrahim A, Mohamed E, Ali O, Hassanein N, Badawy D . The expression of microRNA 146a in patients with ischemic stroke: an observational study. Int J Gen Med. 2019; 12:273-278. PMC: 6691961. DOI: 10.2147/IJGM.S213535. View

14.

Barrasa H, Rello J, Tejada S, Martin A, Balziskueta G, Vinuesa C . SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria. Anaesth Crit Care Pain Med. 2020; 39(5):553-561. PMC: 7144603. DOI: 10.1016/j.accpm.2020.04.001. View

15.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L . Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109(5):531-538. PMC: 7087935. DOI: 10.1007/s00392-020-01626-9. View

16.

Barutta F, Bellini S, Mastrocola R, Bruno G, Gruden G . MicroRNA and Microvascular Complications of Diabetes. Int J Endocrinol. 2018; 2018:6890501. PMC: 5863305. DOI: 10.1155/2018/6890501. View

17.

Prattichizzo F, Giuliani A, De Nigris V, Pujadas G, Ceka A, La Sala L . Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?. Diabetes Obes Metab. 2016; 18(9):855-67. PMC: 5094499. DOI: 10.1111/dom.12688. View

18.

Rebane A, Runnel T, Aab A, Maslovskaja J, Ruckert B, Zimmermann M . MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol. 2014; 134(4):836-847.e11. DOI: 10.1016/j.jaci.2014.05.022. View

19.

Lambert K, Roff A, Panganiban R, Douglas S, Ishmael F . MicroRNA-146a is induced by inflammatory stimuli in airway epithelial cells and augments the anti-inflammatory effects of glucocorticoids. PLoS One. 2018; 13(10):e0205434. PMC: 6177187. DOI: 10.1371/journal.pone.0205434. View

20.

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020; 368:m1091. PMC: 7190011. DOI: 10.1136/bmj.m1091. View